These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial. Portsmouth S; van Veenhuyzen D; Echols R; Machida M; Ferreira JCA; Ariyasu M; Tenke P; Nagata TD Lancet Infect Dis; 2018 Dec; 18(12):1319-1328. PubMed ID: 30509675 [TBL] [Abstract][Full Text] [Related]
5. Compassionate Use of Cefiderocol in the Treatment of an Intraabdominal Infection Due to Multidrug-Resistant Pseudomonas aeruginosa: A Case Report. Stevens RW; Clancy M Pharmacotherapy; 2019 Nov; 39(11):1113-1118. PubMed ID: 31550054 [TBL] [Abstract][Full Text] [Related]
6. Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety. Lee YR; Yeo S Clin Drug Investig; 2020 Oct; 40(10):901-913. PubMed ID: 32700154 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological and clinical profile of cefiderocol, a siderophore cephalosporin against gram-negative pathogens. Jorda A; Zeitlinger M Expert Rev Clin Pharmacol; 2021 Jul; 14(7):777-791. PubMed ID: 33849355 [No Abstract] [Full Text] [Related]
8. Cefiderocol for Infections Caused by Multidrug-Resistant Gram-Negative Bacteria. Weaver K; Stallworth K; Blakely KK Nurs Womens Health; 2020 Oct; 24(5):377-382. PubMed ID: 32890463 [TBL] [Abstract][Full Text] [Related]
9. Cefiderocol, a new antibiotic against multidrug-resistant Gram-negative bacteria. Silva JT; López-Medrano F Rev Esp Quimioter; 2021 Sep; 34 Suppl 1(Suppl1):41-43. PubMed ID: 34598424 [TBL] [Abstract][Full Text] [Related]
10. Cefiderocol treatment of Pseudomonas aeruginosa and extensively drug-resistant Acinetobacter baumannii retained spinal hardware infection causing reversible acute interstitial nephritis: Recto: Cefiderocol causing acute interstitial nephritis. Cipko K; Kizny Gordon A; Adhikari S; Konecny P Int J Infect Dis; 2021 Aug; 109():108-111. PubMed ID: 34157388 [TBL] [Abstract][Full Text] [Related]